Dean Mary Klotman, MD, talks with David Page, Professor and Chair of the Department of Biostatistics and Bioinformatics, about the advantages as well as the potential downsides of AI and Machine Learning, and about how the School of Medicine is working to maximize the opportunities and minimize the risks.

Tik Tok is the health consultant of choice for many Americans. Research by Duke ob-gyn resident Jenny Wu shows some of the social media platform's content can be informative and useful.

Third-year Duke medical student Alexa Campbell is working with Drs. Jeff Federspiel and Sarahn Wheeler in the Department of Ob/Gyn to better understand how racial disparities can lead to negative outcomes in preeclampsia patients.

More children die from pneumonia than AIDS, malaria and measles combined. A DGHI researcher hopes to harness a naturally occurring bacterium to help kids fight back.

In appreciation of the gifts of knowledge and training, the George W. McLean estate has funded an endowment to support endocrinology research.

Graduate students at Duke University who are laying the groundwork for new health care innovations were honored March 1 at the Chancellor’s Award for Research Excellence (CARE) ceremony.

A less extensive surgical option is proving to be an effective method for treating early non-small-cell lung cancer, the most common type of lung cancer, according to a long-term, randomized trial.

Gift by Marion Stein, MD, to support research and faculty at the Duke Human Vaccine Institute.

A groundbreaking advancement in the treatment of geographic atrophy (GA), an advanced form of dry macular degeneration happened with the approval of pegcetacoplan, the first ever FDA-approved treatment for GA.

Dean Mary Klotman talks to Donald McDonnell, PhD, the Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology about the FDA-approved breakthrough drug for breast cancer developed in his Duke lab.